1. Home
  2. CAAS vs HRTX Comparison

CAAS vs HRTX Comparison

Compare CAAS & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CAAS

China Automotive Systems Inc.

N/A

Current Price

$4.29

Market Cap

127.3M

ML Signal

N/A

Logo Heron Therapeutics Inc.

HRTX

Heron Therapeutics Inc.

HOLD

Current Price

$0.79

Market Cap

146.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAAS
HRTX
Founded
N/A
1983
Country
China
United States
Employees
4414
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
127.3M
146.8M
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
CAAS
HRTX
Price
$4.29
$0.79
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.50
AVG Volume (30 Days)
19.1K
1.7M
Earning Date
05-13-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$154,904,000.00
Revenue This Year
N/A
$15.28
Revenue Next Year
N/A
$20.29
P/E Ratio
$3.97
N/A
Revenue Growth
N/A
7.36
52 Week Low
$3.50
$0.74
52 Week High
$5.15
$2.61

Technical Indicators

Market Signals
Indicator
CAAS
HRTX
Relative Strength Index (RSI) 40.78 35.50
Support Level $4.11 $0.74
Resistance Level $4.39 $0.87
Average True Range (ATR) 0.13 0.06
MACD 0.00 0.01
Stochastic Oscillator 33.33 39.07

Price Performance

Historical Comparison
CAAS
HRTX

About CAAS China Automotive Systems Inc.

China Automotive Systems Inc is a holding company. The firm through its subsidiary is a supplier of power steering systems and components to China's automotive industry. Its product offering encompasses a full range of auto parts incorporated into steering systems for both passenger automobiles and commercial vehicles. The company offers four separate series, models of power steering including rack and pinion power steering, integral power steering, electronic power steering and manual steering, steering columns, steering oil pumps, and steering hoses. Geographically, it derives a majority of its revenue from China.

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Share on Social Networks: